Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
Nat Biotechnol. 2020 Apr;38(4):471-481. doi: 10.1038/s41587-020-0412-8. Epub 2020 Feb 10.
The targeting scope of Streptococcus pyogenes Cas9 (SpCas9) and its engineered variants is largely restricted to protospacer-adjacent motif (PAM) sequences containing G bases. Here we report the evolution of three new SpCas9 variants that collectively recognize NRNH PAMs (where R is A or G and H is A, C or T) using phage-assisted non-continuous evolution, three new phage-assisted continuous evolution strategies for DNA binding and a secondary selection for DNA cleavage. The targeting capabilities of these evolved variants and SpCas9-NG were characterized in HEK293T cells using a library of 11,776 genomically integrated protospacer-sgRNA pairs containing all possible NNNN PAMs. The evolved variants mediated indel formation and base editing in human cells and enabled A•T-to-G•C base editing of a sickle cell anemia mutation using a previously inaccessible CACC PAM. These new evolved SpCas9 variants, together with previously reported variants, in principle enable targeting of most NR PAM sequences and substantially reduce the fraction of genomic sites that are inaccessible by Cas9-based methods.
化脓链球菌 Cas9(SpCas9)及其工程变体的靶向范围在很大程度上仅限于含有 G 碱基的原间隔邻近基序(PAM)序列。在这里,我们报告了三种新的 SpCas9 变体的进化,它们共同使用噬菌体辅助非连续进化、三种新的噬菌体辅助 DNA 结合连续进化策略和 DNA 切割的二次选择来识别 NRNH PAMs(其中 R 是 A 或 G,H 是 A、C 或 T)。使用包含所有可能的 NNNN PAMs 的 11,776 个基因组整合的原间隔子 sgRNA 对文库,在 HEK293T 细胞中对这些进化变体和 SpCas9-NG 的靶向能力进行了表征。进化变体介导了人细胞中的缺失形成和碱基编辑,并使用以前无法访问的 CACC PAM 实现了镰状细胞贫血突变的 A•T 到 G•C 碱基编辑。这些新的进化 SpCas9 变体与以前报道的变体一起,原则上可以靶向大多数 NR PAM 序列,并大大减少了 Cas9 基方法无法访问的基因组位点的分数。